Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With Itch

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Mild to moderate eczema, as determined by the investigator (score of 2.0-7.5 on Rajka-Langeland severity index).~* Has 1 target lesion, as determined by the investigator (score of 6-12 on Atopic Dermatitis Severity Index (ADSI) and sub-score of at least 2 on erythema and pruritus).~* Experienced a recent itch flare up and is experiencing pre-flare up symptoms at screening.~* Did not use moisturizer on the face and body for 3 days prior to screening.~* Has a score of at least 4.0 on Visual Analog Scale (VAS) Itch Assessment scale at baseline.~* Generally in good health.~* Willing to stop using all topical emollients, moisturizers, and/or other skin barrier creams and/or emulsion treatments for the eczema condition during the test period.~* Willing and able to follow all study directions, including avoiding excessive sun exposure (including tanning beds), and to commit to all follow up visits for the duration of the study.~* Completed informed consent/assent process and signed photograph release.~* Must agree to practice a medically acceptable form of birth control.~Exclusion Criteria:~* Known allergies or sensitivities to test product ingredients.~* Severe eczema.~* Using a therapeutic (over the counter or prescription) body wash that contains an active ingredient for eczema.~* Has a health condition or skin condition that the study investigator thinks could increase risk to the subject or confuse study results (e.g. immune deficiency disorders).~* Has been using that the study investigator thinks could increase risk to the subject or confuse study results (e.g. corticosteroids, immunosuppressive medications).~* Currently participating in another study.~* Subjects who have clinically active bacterial, fungal, or viral skin infections or those who are susceptible to cutaneous infections.~* Has any planned surgery and/or invasive medical procedures scheduled during the course of the study.

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- OTC Eczema Moisturizer Regimen (Type: EXPERIMENTAL): Subjects who were assigned to use an over-the-counter (OTC), oatmeal-containing eczema therapy moisturizing cream. The product is classified as an OTC monograph drug.
- Cosmetic Moisturizer Regimen (Type: EXPERIMENTAL): Subjects who were assigned to use a non-fragranced, dry skin daily moisturizer classified as a cosmetic (i.e. non-OTC).

Based on this trial design, predict the completion outcome and termination type (if applicable).